@Sh0kDynasty $KTOV ''A second cohort of patients, ... , will be dosed with NT219, dose escalated, in combination with cetuximab.''

Cetuximab is approved for K-RAS wild-type metastatic colorectal cancer in the US &amp; Canada (Eli Lilly $LLY). In Europe and the rest of the world (Merck $MRK).